Comparison of Alprostadil (Caverject) and a combination of vasoactive drugs as local injections for the treatment of erectile dysfunction

International Urology and Nephrology

Volumn 30, Issue 5, 1998, Pages 617-620

  Abdallah, H M ^a  

^a AIN SHAMS UNIVERSITY   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

PAPAVERINE; PHENTOLAMINE MESYLATE; PROSTAGLANDIN E1; VASOACTIVE AGENT;

ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG INDUCED DISEASE; ERECTILE DYSFUNCTION; HUMAN; HYPOTENSION; INJECTION SITE; INTERMETHOD COMPARISON; INTRACAVERNOUS DRUG ADMINISTRATION; MALE; MALE SEXUAL DYSFUNCTION; PENIS ERECTION; PRIAPISM; TREATMENT OUTCOME;

EID: 0032430590     PISSN: 03011623     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02550556     Document Type: Article

References (6)

1. Dimitrios, G H., Terry, P., Irwin, G : Intracavernous injection therapy for impotence. Management of impotence and infertility. J. B. Lippincott Company, Philadelphia 1994, PP. 12-27
2. Zorgmotti, A. W., Lefleur, R. S.: Autoinjection of the corpus cavernosum with a vasoactive combination for vasculogenic impotence. J. Urol., 133, 39 (1985).
3. Maria, W., Paul, S : Efficiency and side effects of prostaglandin E1 in the treatment of erectile dysfunction J. Urol , 140, 525 (1988).
4. McMahon, C. G.: A comparison of the response to the intracavernosal injection of a combination of papaverine and phentolamine prostaglandin PGE1 and a combination of all 3 agents in the management of impotence. Int. J. Impotence Res., 3, 113 (1991).
5. Andersson, K E , Holmquist, F , Wagner, G.: Pharmacology of drugs used for treatment of erectile dysfunction and priapism. Int. J. Impotence Res , 3, 155 (1991).
6. Walter, S , Rudolf, H., Michael, M.: Intracavernous injection of Prostaglandin E1 in impotent men J. Urol., 140, 66 (1988).